Recent Posts

Samsung to explore next-gen biologics

Bloomberg The Samsung brand is best known for its smartphones and wide-screen TVs. Yet behind the scenes, the conglomerate is also making a name as a contract manufacturer of complex medicines to treat diseases like cancer. On a piece of reclaimed land along the western coast of South Korea, Samsung BioLogics Co. is building a $740 million factory that will ...

Read More »

Noble climbs even as Moody’s flags $900mn funding gap

Bloomberg After a savage three-day sell-off, Noble Group Ltd. shares climbed on Tuesday even as Moody’s Investors Service joined S&P Global Ratings in highlighting the embattled commodity trader’s finances, saying that estimated liquidity isn’t sufficient to cover debt due by mid-2018. Moody’s said that while the liquidity headroom, including cash and unused committed facilities, was $2.4 billion at end of ...

Read More »

Asian exports may be about to slow down

Bloomberg The Great Asian Export Spurt may be about to end, replaced by a stretch of merely good exports. Demand from both Chinese consumers and manufacturers, a key driver for an unexpected jump in Asian exports so far this year, is likely to moderate as Beijing shifts focus toward economic re-balancing, and corporate China slows a massive inventory buildup, Credit ...

Read More »
Send this to a friend